Jockey Club’s Revised Drug Rules Have Salix Provision
Tom LaMarra
August 13, 2012
The Jockey Club has added a provision governing regulatory administration of furosemide on race day.
The Jockey Club has added a provision governing regulatory administration of furosemide on race day.
Race-day Salix will not be allowed in listed stakes races for 2-year-old Thoroughbreds.
SHOW claims their demise will put horses at greater risk of abuse by trainers who sore the animals.
The treatment and drug records of horses running in the Travers Stakes will be updated daily online.
The commission plans to hold a fact-finding meeting on use of race-day furosemide day, officials said Aug. 4.
The organization is waiting on UC Davis study results before ruling on a possible ban of clenbuterol.
The majority of the National HBPA affiliates have adopted pro-race-day Salix resolutions.
SHOW and two other HIOs were deemed noncompliant by the USDA for not submitting modified rule books.
Three HIOs have been deemed noncompliant for failing to comply with new HPA enforcement rules.
A new grassroots organization that opposes race-day medication wants involvement by the federal government.
The rule would affect found responsible for putting substances in racehorses that might endanger the animals.
Discussion topics included public veterinary records, commission authority over veterinarians, and Salix.
GABA is an inhibitory neurotransmitter and is a principal ingredient of the product “Carolina Gold.”
The BLM is proposing to gather 498 wild horses and remove approximately 400 excess wild horses from the range.
The USDA might decertify five Tennessee Walking Horse HIOs for not complying with new HPA enforcement rules.
The two-day event will bring together a cross-section of the breeding, racing, and veterinary communities.
Stay on top of the most recent Horse Health news with
